|
|
Volumn 83, Issue 21, 2005, Pages 24-25
|
|
Drug firms report a decent quarter
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CHEMICAL INDUSTRY;
COMPETITION;
COST BENEFIT ANALYSIS;
DRUG PRODUCTS;
INDUSTRIAL ECONOMICS;
MARKETING;
PRODUCTIVITY;
SALES;
ASTRAZENECA (CO);
JOHNSON & JOHNSON (CO);
MERCK (CO);
NOVARTIS (CO);
PFIZER (CO);
WYETH (CO);
DRUG PRODUCTS PLANTS;
|
|
EID: 20144372634
PISSN: 00092347
EISSN: None
Source Type: Trade Journal
DOI: 10.1021/cen-v083n021.p024 Document Type: Short Survey |
|
Times cited : (7)
|
|
References (0)
|